Management Strategies in Antithrombotic Therapy (PDF)
(Sprache: Englisch)
Intravascular thrombus formation remains one of the most
significant problems in cardiovascular medicine. It underlies the
clinical presentation of acute coronary syndromes, including
unstable angina and non-ST-segment elevation myocardial...
significant problems in cardiovascular medicine. It underlies the
clinical presentation of acute coronary syndromes, including
unstable angina and non-ST-segment elevation myocardial...
sofort als Download lieferbar
eBook (pdf)
141.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Management Strategies in Antithrombotic Therapy (PDF)“
Intravascular thrombus formation remains one of the most
significant problems in cardiovascular medicine. It underlies the
clinical presentation of acute coronary syndromes, including
unstable angina and non-ST-segment elevation myocardial infarction
(NSTEMI) and ST-segment elevation myocardial infarction.
More and more individuals are stricken with an acute MI and
undergo a percutaneous coronary intervention (PCI). Several reasons
apply, including an increasingly aged population, the growing
burden of chronic risk factors such as diabetes, obesity, sedentary
behaviour, and improvements in early recognition and intervention.
Thrombus formation also results in substantial morbidity and
mortality. Despite significant advances in prevention and treatment
of venous thromboembolism, pulmonary embolism remains a common
preventable cause of hospital deaths. Implementing the most
appropriate, and safe, anticoagulation therapy across the spectrum
of cardiovascular disease in the presence of a wide range of other
risk factors remains a challenge.
Written by leading authorities in the field, Management
Strategies in Antithrombotic Therapy offers a comprehensive
review of antithrombotic therapy, including the latest therapies,
risk factors and evidence-based strategy. The book acquaints
readers with the data behind the commonly used antithrombotic
agents and assists them in formulating a sound, evidence-based
therapeutic strategy appropriate for each patient.
This book is an invaluable resource for all postgraduate
students and specialist physicians in cardiovascular medicine,
cardiac and vascular surgery, and critical care.
significant problems in cardiovascular medicine. It underlies the
clinical presentation of acute coronary syndromes, including
unstable angina and non-ST-segment elevation myocardial infarction
(NSTEMI) and ST-segment elevation myocardial infarction.
More and more individuals are stricken with an acute MI and
undergo a percutaneous coronary intervention (PCI). Several reasons
apply, including an increasingly aged population, the growing
burden of chronic risk factors such as diabetes, obesity, sedentary
behaviour, and improvements in early recognition and intervention.
Thrombus formation also results in substantial morbidity and
mortality. Despite significant advances in prevention and treatment
of venous thromboembolism, pulmonary embolism remains a common
preventable cause of hospital deaths. Implementing the most
appropriate, and safe, anticoagulation therapy across the spectrum
of cardiovascular disease in the presence of a wide range of other
risk factors remains a challenge.
Written by leading authorities in the field, Management
Strategies in Antithrombotic Therapy offers a comprehensive
review of antithrombotic therapy, including the latest therapies,
risk factors and evidence-based strategy. The book acquaints
readers with the data behind the commonly used antithrombotic
agents and assists them in formulating a sound, evidence-based
therapeutic strategy appropriate for each patient.
This book is an invaluable resource for all postgraduate
students and specialist physicians in cardiovascular medicine,
cardiac and vascular surgery, and critical care.
Inhaltsverzeichnis zu „Management Strategies in Antithrombotic Therapy (PDF)“
Abbreviations and Acronyms. Preface. Chapter 1. Thrombosis and Antithrombotics in Vascular Disease. 1.1 The Burden of Thrombosis. 1.2 Essential components of thrombosis. 1.3 Thrombosis in the acute ischemic syndromes. 1.4 Venous thromboembolic disease. 1.5 The ideal antithrombotic agent. Chapter 2. Aspirin. 2.1 Introduction. 2.2 Pharmacology. 2.3 Clinical uses of aspirin. 2.4 Conclusions. Chapter 3. Thienopyridines - Ticlopidine and Clopidogrel. 3.1 Introduction. 3.2 Pharmacology. 3.3 Clinical uses of the thienopyridines. 3.4 Conclusions. Chapter 4. Platelet Glycoprotein IIb/IIIa Inhibitors. 4.1 Introduction. 4.2 GP IIb/IIIa receptor inhibitors. 4.3 GP IIb/IIIa inhibitors during percutaneous coronary revascularization. 4.4 GP IIb/IIIa inhibitors in the management of non-st-elevation ACS. 4.5 GP IIb/IIIa inhibitors in the management of acute STEMI. 4.6 Safety of GP IIb/IIIa inhibitors. 4.7 Summary. Chapter 5. Unfractionated Heparin. 5.1 Introduction. 5.2 Pharmacology. 5.3 Clinical uses of UH. 5.4 Clinical considerations. 5.5 Conclusions. Chapter 6. Low-Molecular-Weight Heparins. 6.1 Introduction. 6.2 Comparisons between UH and LMWH. 6.3 Clinical uses of LMWH. 6.4 Conclusions. Chapter 7 Direct Thrombin Inhibitors. 7.1 Introduction. 7.2 Overview of DTIs. 7.3 Clinical uses of DTIs. 7.4 Summary. Chapter 8. Fibrinolytic agents. 8.1 Introduction. 8.2 Fibrinolytic agents for STEMI. 8.3 Fibrinolytics for VTE. 8.4 Conclusions. Chapter 9. Acute ST-Segment-Elevation Myocardial Infarction. 9.1 Introduction. 9.2 Definitive therapy. 9.3 Adjunctive therapy. 9.4 Recommendations. 9.5 Conclusions. Chapter 10. Acute Coronary Syndromes: Unstable Angina /Non-ST-Segment-Elevation Myocardial Infarction (NSTE ACS). 10.1 Introduction. 10.2 Antithrombotic approach to patients with ACS/NSTEMI. 10.3 Early invasive versus early conservative strategies. 10.4 Recommendations. 10.5 Conclusions. Chapter 11 Anticoagulation Strategies for Patients Undergoing Percutaneous Coronary Intervention. 11.1
... mehr
Introduction. 11.2 Antiplatelet therapy. 11.3 Antithrombotic therapy. 11.4 Special populations. 11.5 Recommendations. 11.6 Conclusions. Chapter 12 Venous Thromboembolic Disease. 12.1 Introduction. 12.2 Risk of VTE. 12.3 Prevention of VTE. 12.4 Treatment of VTE. 12.5 Conclusions. Chapter 13. Heparin-Induced Thrombocytopenia. 13.1 Introduction. 13.2 Incidence. 13.3 Pathogenesis. 13.4 Clinical manifestations. 13.5 Diagnosis. 13.6 Prevention. 13.7 Treatment. 13.8 Conclusions. Index.
... weniger
Autoren-Porträt von Arman Askari, Michael Lincoff, Adrian Messerli
Arman T. Askari, MD. Associate Director, CardiovascularMedicine Training Program, The Cleveland Clinic, Ohio, USA
Dr Michael A. Lincoff, MD. Department of Cardiovascular
Medicine, Cleveland Clinic Heart Center, The Cleveland Clinic,
Ohio, USA
Bibliographische Angaben
- Autoren: Arman Askari , Michael Lincoff , Adrian Messerli
- 2008, 1. Auflage, 366 Seiten, Englisch
- Verlag: John Wiley & Sons
- ISBN-10: 0470518146
- ISBN-13: 9780470518144
- Erscheinungsdatum: 02.08.2008
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 2.82 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Management Strategies in Antithrombotic Therapy"
0 Gebrauchte Artikel zu „Management Strategies in Antithrombotic Therapy“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Management Strategies in Antithrombotic Therapy".
Kommentar verfassen